Murakami T - Search Results

1

Author Correction: Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy.

Murakami T, Sato T, Adachi M, Ishiguro K, Shichiji M, Tachimori H, Nagata S, Ishigaki K. Murakami T, et al. Sci Rep. 2022 Aug 2;12(1):13263. doi: 10.1038/s41598-022-17588-z. Sci Rep. 2022. PMID: 35918519 Free PMC article. No abstract available.

2

Benefits of FK 506 for refractory eye symptoms in a young child with ocular myasthenia gravis.

Ishigaki K, Shishikura K, Murakami T, Suzuki H, Hirayama Y, Osawa M. Ishigaki K, et al. Among authors: murakami t. Brain Dev. 2009 Sep;31(8):634-7. doi: 10.1016/j.braindev.2008.08.016. Epub 2008 Oct 9. Brain Dev. 2009. PMID: 18845408

3

[Treatment approach to congenital myasthenic syndrome in a patient with acetylcholine receptor deficiency].

Ishigaki K, Murakami T, Ito Y, Yanagisawa A, Kodaira K, Shishikura K, Suzuki H, Hirayama Y, Osawa M. Ishigaki K, et al. Among authors: murakami t. No To Hattatsu. 2009 Jan;41(1):37-42. No To Hattatsu. 2009. PMID: 19172815 Japanese.

4

High-density areas on muscle CT in childhood-onset Pompe disease are caused by excess calcium accumulation.

Ishigaki K, Mitsuhashi S, Kuwatsuru R, Murakami T, Shishikura K, Suzuki H, Hirayama Y, Nonaka I, Osawa M. Ishigaki K, et al. Among authors: murakami t. Acta Neuropathol. 2010 Oct;120(4):537-43. doi: 10.1007/s00401-010-0732-8. Epub 2010 Aug 3. Acta Neuropathol. 2010. PMID: 20680637

5

Close monitoring of initial enzyme replacement therapy in a patient with childhood-onset Pompe disease.

Ishigaki K, Murakami T, Nakanishi T, Oda E, Sato T, Osawa M. Ishigaki K, et al. Among authors: murakami t. Brain Dev. 2012 Feb;34(2):98-102. doi: 10.1016/j.braindev.2011.05.004. Epub 2011 Jun 14. Brain Dev. 2012. PMID: 21676566

6

High-density CT of muscle and liver may allow early diagnosis of childhood-onset Pompe disease.

Ishigaki K, Yoshikawa Y, Kuwatsuru R, Oda E, Murakami T, Sato T, Saito T, Umezu R, Osawa M. Ishigaki K, et al. Among authors: murakami t. Brain Dev. 2012 Feb;34(2):103-6. doi: 10.1016/j.braindev.2011.05.013. Epub 2011 Jun 24. Brain Dev. 2012. PMID: 21704464

7

Severe muscle damage following viral infection in patients with Fukuyama congenital muscular dystrophy.

Murakami T, Ishigaki K, Shirakawa S, Ikenaka H, Sakauchi M, Osawa M. Murakami T, et al. Brain Dev. 2012 Apr;34(4):293-7. doi: 10.1016/j.braindev.2011.06.002. Epub 2011 Jul 2. Brain Dev. 2012. PMID: 21726969

8

Respiratory management of patients with Fukuyama congenital muscular dystrophy.

Sato T, Murakami T, Ishiguro K, Shichiji M, Saito K, Osawa M, Nagata S, Ishigaki K. Sato T, et al. Among authors: murakami t. Brain Dev. 2016 Mar;38(3):324-30. doi: 10.1016/j.braindev.2015.08.010. Epub 2015 Sep 9. Brain Dev. 2016. PMID: 26363734

9

The gross motor function measure is valid for Fukuyama congenital muscular dystrophy.

Sato T, Adachi M, Nakamura K, Zushi M, Goto K, Murakami T, Ishiguro K, Shichiji M, Saito K, Ikai T, Osawa M, Kondo I, Nagata S, Ishigaki K. Sato T, et al. Among authors: murakami t. Neuromuscul Disord. 2017 Jan;27(1):45-49. doi: 10.1016/j.nmd.2016.09.014. Epub 2016 Sep 20. Neuromuscul Disord. 2017. PMID: 27818010

10

Renal dysfunction is rare in Fukuyama congenital muscular dystrophy.

Ishigaki K, Kato I, Murakami T, Sato T, Shichiji M, Ishiguro K, Ishizuka K, Funatsuka M, Saito K, Osawa M, Nagata S. Ishigaki K, et al. Among authors: murakami t. Brain Dev. 2019 Jan;41(1):43-49. doi: 10.1016/j.braindev.2018.07.012. Epub 2018 Aug 1. Brain Dev. 2019. PMID: 30077507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,679 results

Search Page

Filters